Video-Assisted Vs Thoracotomy Sleeve Lobectomy for Lung Cancer: A Propensity Matched Analysis

Gao, Hui; Jiang, Zhen; Gong, Lei; Ma, Kai; Ren, Peng; Yu, Zhen; Yu, Wei

doi:10.1016/j.athoracsur.2019.04.037

Cited by 42 publications

(61 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This study showed that the local recurrence rate after VATS sleeve resection was 0%. These survival and recurrence outcome were comparable to the outcomes of conventional sleeve lobectomy in the literature [1,5,12,14,15,24,25]. In 2013, Kasprzyk et al [26] have reported that the 5-year survival rate after conventional sleeve lobectomy was 56.1%, and the local recurrence rate was 9.3%.…”

Section: Discussionsupporting

confidence: 67%

“…Since the first case report on the use of VATS sleeve lobectomy, published in 2002 [7], it has been used steadily by some thoracic surgeons [8][9][10][11]. Some retrospective studies have shown that VATS sleeve lobectomy is a safe and feasible surgical procedure for treating centrally located NSCLC with comparable perioperative and survival outcomes to the thoracotomy approach [12][13][14][15][16].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer

et al. 2021

View full text Add to dashboard Cite

Purpose: Sleeve lobectomy is a safe and effective surgical procedure for centrally located non-small cell lung cancer (NSCLC). However, the use of video-assisted thoracoscopic surgery (VATS) on bronchial sleeve resection is still controversial due to a lack of evidence. In this study, we describe our experience on VATS sleeve lobectomy and evaluate its feasibility for treating NSCLC. Methods: From January 2010 to May 2019, VATS sleeve lobectomy was attempted in 19 patients with NSCLC at Samsung Medical Center. Their baseline characteristics, perioperative data, and survival outcome were collected and analyzed retrospectively. Results: Of the 19 patients, 10 underwent VATS sleeve lobectomy successfully. The mean age of the patients who underwent successful VATS was 53.5 ± 15.8 years, and all the patients were men. Seven patients (70%) had squamous cell carcinoma. The mean postoperative chest tube drainage duration was 5.3 ± 2.3 days, and the median hospital stay duration was 7 days (interquartile range, 6.25 to 11.5 days). Among the patients who underwent successful VATS, two had postoperative bronchial stenosis: One patient underwent complete pneumonectomy, and one patient was observed without any intervention. During the median follow-up duration of 3.5 years, two patients with squamous cell carcinoma who underwent successful VATS died. Of these, one died 70 days postoperatively because of acute respiratory distress syndrome and one died 18 months postoperatively from an unknown cause. No patient had locoregional recurrence. Conclusion: VATS sleeve lobectomy is a feasible surgical procedure for centrally located tumors without vascular invasion.

show abstract

Section: Discussionsupporting

confidence: 67%

Section: Introductionmentioning

confidence: 99%

Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer

et al. 2021

View full text Add to dashboard Cite

show abstract

“…By increased experience, more complex cases are dared to be performed by thoracic surgeons, such as sleeve resections, operations in patients who have received neoadjuvant treatment, chest wall invasions and pneumonectomies. [13][14][15][16] According to Li et al, [15] a thoracic surgeon should perform between 100 and 200 VATS resections to achieve efficiency. Over time, we aim to enhance our experience with cases and attempt VATS resections in larger and more complicated cases.…”

Section: Discussionmentioning

confidence: 99%

Comparison of Video-assisted Thoracoscopic Lobectomy versus Open Thoracotomy for Primary Non Small Cell Lung Cancer - 269 Cases Single Cohort Study

Erdoğu¹

2020

Sisli Etfal

View full text Add to dashboard Cite

M any centers worldwide perform lobectomy by video-assisted thoracoscopic surgery (VATS) as an alternative to open thoracotomy in suitable cases, especially in early stage non-small cell lung cancer (NSCLC) cases. [1] According to many studies, the advantages of VATS lobectomy compared to conventional open thoracotomy include shorter length of hospitalization, less postoperative complications, shorter duration of the chest tube, a more cosmetic incision, less postoperative pain, therefore better postoperative life quality and importantly similar overall survival rates compared to open thoracotomy. [2-4] VATS resections have become increasingly popular worldwide following the improvements in training programmes, drawing young surgeons' interest in VATS lobectomy, leading to increased experience. [5] In our Thoracic Surgery Clinic, VATS lobectomy is being performed since the beginning of the 2010s. VATS experience of Objectives: This study aims to compare the outcomes of video-assisted thoracoscopic surgery (VATS) lobectomy with open thoracotomy lobectomy in patients with non-small cell lung cancer (NSCLC). Methods: There were 269 cases with NSCLC who underwent lobectomy between 2017-2019; these cases were retrospectively studied. VATS lobectomy (VATS Group) and open thoracotomy lobectomy (Thoracotomy Group) patients' results were compared according to the length of hospitalizations, early postoperative complications and tumor size and stages. Results: VATS lobectomy was performed in 89 (33%) of these patients, whereas 180 (67%) patients underwent lobectomy using open thoracotomy for NSCLC. The findings showed that the average length of hospitalization was shorter in the VATS Group compared to the Thoracotomy Group (4 vs. 5.5 days) (p<0.05). It was found that the mean size of the tumour was smaller in the VATS Group when compared to the Thoracotomy Group (2.66 cm vs 3.97 cm) (p<0.001). Early postoperative complications were lower in the VATS Group (n=15, 16.8% vs n=58, 32.2%; p<0.021). Conclusion: In VATS lobectomy cases, postoperative complications are less, and the length of hospitalization is shorter. VATS lobectomy is mostly preferred smaller than 3 cm tumor size.

show abstract

“…Moreover, recurrence-free survival and overall survival were better in patients who underwent VATS resection, even though the difference did not reach statistical significance. Gao therefore claimed that VATS sleeve lobectomy was a safe procedure, with oncological outcomes comparable to those after thoracotomy sleeve lobectomy and a faster postoperative recovery (55). It should also be considered that the more rapid healing after VATS surgery could lead to an earlier start of adjuvant chemotherapy, which in these cases is often indicated (56).…”

Section: Discussionmentioning

confidence: 99%

Sleeve video-assisted thoracic surgery resections

Tosi¹,

Musso²,

Damarco³

et al. 2020

Curr Chall Thorac Surg

View full text Add to dashboard Cite

Lung resections with bronchoplastic techniques play an important role in the preservation of lung function, in patients with centrally located tumors. Several studies reported oncological outcomes after sleeve resections comparable to pneumonectomy, with lower postoperative mortality and morbidity.Sleeve lobectomy is now considered the procedure of choice for anatomically suitable lesions, regardless of pulmonary function, but is still considered a challenging and technically demanding procedure, especially when carried out by video-assisted thoracic surgery (VATS) approach. The aim of this review article is to describe indications, technical aspects and outcomes of VATS sleeve resections.

show abstract

Video-Assisted Vs Thoracotomy Sleeve Lobectomy for Lung Cancer: A Propensity Matched Analysis

Cited by 42 publications

References 28 publications

Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer

Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer

Comparison of Video-assisted Thoracoscopic Lobectomy versus Open Thoracotomy for Primary Non Small Cell Lung Cancer - 269 Cases Single Cohort Study

Sleeve video-assisted thoracic surgery resections

Contact Info

Product

Resources

About